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We hypothesize that dysregulation of the epithelial sodium
channel (ENaC) may be responsible for the increased sodium
retention in liver cirrhosis. Liver cirrhosis was induced by
common bile duct ligation (CBDL). We examined the
abundance of ENaC subunits and type 2 isoform of
11b-hydroxysteroid dehydrogenase (11bHSD2) in the kidney
by immunoblotting and immunohistochemistry at 6 or 8
weeks after operation. At 6 weeks, cirrhotic rats had
developed ascites and displayed a positive sodium balance.
The urinary sodium excretion and fractional excretion of
sodium were decreased, while plasma aldosterone was
unchanged. The abundance of ENaC subunits was not
changed in the cortex and outer stripe of the outer medulla
(OSOM). In contrast, immunoperoxidase microscopy revealed
an increased apical targeting of a-, b- and cENaC in late distal
convoluted tubule, connecting tubule and collecting duct.
Moreover, 11bHSD2 abundance was decreased in the cortex/
OSOM and inner stripe of the outer medulla. At 8 weeks,
urinary sodium excretion and fractional excretion of sodium
were not changed, while the plasma aldosterone level was
decreased. The expression of ENaC subunits was decreased in
the cortex/OSOM. Immunoperoxidase microscopy confirmed
decreased expression of ENaC subunits, whereas subcellular
localization was not changed. These results suggest that
increased apical targeting of ENaC subunits and diminished
abundance of 11bHSD2 may contribute to promote sodium
retention in the sodium-retaining stage of liver cirrhosis (at 6
weeks). The subsequent decreased expression and reduced
targeting of ENaC subunits may play a role in promoting
sodium excretion in the later stage of liver cirrhosis (at 8
weeks).
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Liver cirrhosis is a chronic disease with marked progressive
changes in systemic and renal hemodynamics. Initially, liver
cirrhosis patients have peripheral vasodilatation and in-
creased cardiac output but do not have clinical signs of fluid
retention (the compensated state). During the late decom-
pensated state, liver cirrhosis is associated with sodium
retention, edema and ascites. Sodium retention is the most
frequent renal functional abnormality in patients and animal
models with liver cirrhosis.1 However, the mechanism for the
sodium retention is still incompletely understood and the
molecular basis remains undefined.
As sodium retention is usually associated with a marked
activation of the renin–aldosterone system and can be
reversed by spironolactone, a specific antagonist of the
tubular effect of aldosterone,2 it has been suggested that
hyperaldosteronism is among the most important mechan-
isms involved in the avid sodium retention in patients with
decompensated liver cirrhosis. However, evidence provided
by several studies indicates that the extent of sodium
retention and potassium loss cannot be explained completely
by the elevated aldosterone concentrations in cirrhotic
patients, and renal sodium retention precedes ascites
formation.2–4 Previous findings indicate that aldosterone
may be normal in a significant proportion of patients with
ascites.5 Although plasma aldosterone levels are not in-
creased, it is well known that treatment with mineralocorti-
coid receptor (MR) antagonists can prevent sodium retention
in animal models of cirrhosis2,6 and, clinically, aldosterone
antagonists are the established first choice in the treatment of
cirrhotic ascites and edema.7 It has therefore been suggested
that the sensitivity of the collecting duct to aldosterone is
increased in liver cirrhosis. Consistent with this, the activity
of type 2 11b-hydroxysteroid dehydrogenase (11bHSD2), an
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enzyme which normally protects the MR from stimulation by
glucocorticoids, is significantly decreased in microdissected
cortical collecting tubules from rats with liver cirrhosis
induced by common bile duct ligation (CBDL).8 The
occupancy of MR by glucocorticoid hormone will lead to
permanent maximal sodium retention. If this mechanism is
operative in rats with liver cirrhosis, collecting duct sodium
reabsorption might well be stimulated even in the presence of
normal plasma levels of aldosterone.
As the epithelial sodium channel (ENaC) mediates the
major sodium transport in the collecting duct9 and both
protein abundance and apical membrane targeting of ENaC
are regulated by hormones such as aldosterone10 and
vasopressin,11 we speculate that altered expression and/or
apical membrane targeting of ENaC subunits (a, b and g)
may account for the increased sodium absorption in the
distal nephron and the collecting ducts in liver cirrhosis. The
purpose of this study was therefore to investigate whether
CBDL-induced decompensated liver cirrhosis in rats is
associated with altered regulation of ENaC subunit protein
abundance and/or changes in the segmental and subcellular
localization.
RESULTS
Urinary sodium excretion and fractional excretion of sodium
were decreased in rats with 6-week cirrhosis (Table 1)
We established a window at 6 weeks after bile duct ligation as
a critical time point at which ascites develops in rats. At 6
weeks, CBDL-induced cirrhotic rats developed significant
ascites, and exposure of the abdomen at the termination of
the study showed that the cirrhotic rats had a large amount of
ascites. After 6 weeks, the quantity of peritoneal fluid in
cirrhotic rats was significantly greater than in controls.
Plasma concentrations of alanine aminotransaminase (ALAT)
and bilirubin were significantly increased in cirrhotic rats.
Plasma creatinine levels were not changed, whereas renal
creatinine clearance was significantly decreased in rats with
CBDL. Importantly, the 24-h urinary sodium excretion and
fractional excretion of sodium were significantly decreased at
6 weeks in rats with CBDL compared with controls.
Consequently, cirrhotic rats displayed a positive sodium
balance. The urinary Na/K ratio was markedly decreased in 6-
week CBDL rats, indicating increased aldosterone effective-
ness in the distal nephron. Accordingly, fractional excretion
of potassium was increased. On the other hand, plasma
aldosterone levels were not changed in rats with 6-week
CBDL.
The protein abundance of ENaC subunits was not changed in
the kidney cortex/outer stripe of the outer medulla in rats
with 6-week CBDL
The protein abundance of aENaC was not changed in the
cortex/outer stripe of the outer medulla (OSOM), while it
was increased in the inner stripe of the outer medulla (ISOM)
in rats with 6-week CBDL compared with controls (Figure 1).
The abundance of bENaC was not changed in the cortex/
OSOM and ISOM. The 85 kDa band abundance of gENaC
was decreased in the cortex/OSOM (Figure 1, Table 2), but
not in the ISOM. However, total gENaC abundance and
70 kDa band expression were not changed in the cortex/
OSOM and ISOM. The analyses of normalized band densities
are shown in Table 2.
Increased membrane targeting of ENaC subunits in rats with
6-week CBDL
In control rats, immunoperoxidase staining for the bENaC
subunits showed diffuse punctuate labeling throughout the
distal convoluted tubule (DCT2), connecting tubule (CNT)
and collecting duct principal cells. At 6-weeks in CBDL rats,
bENaC labeling was predominantly localized to the apical
domains (i.e. plasma membrane and intracellular vesicles
close to the membrane), with only marginal labeling of the
cytoplasm corresponding to labeling of intracellular vesicles.
This increased apical targeting was evident in almost all
cross-sectioned tubules of DCT2 (not shown), CNT (Figure
2a and b), cortical collecting duct (CCD, Figure 2c and d)
and outer medullary collecting duct (OMCD) (not shown).
Moreover, immunohistochemical analysis also revealed
similar changes in the subcellular distribution of gENaC in
kidneys from 6-week CBDL rats. There was a marked increase
in apical gENaC immunolabeling in DCT2 (not shown),
CNT (Figure 2e and f), CCD (Figure 2g and h) and OMCD
Table 1 | Changes in hepatic and renal function in control rats
and rats with 6-week CBDL
Control (n=7) Cirrhosis (n=10)
Body weight (g) 31272 29578
Food intake (g) 16.770.5 13.771.9
Water intake (ml) 23.470.6 21.972.5
Ascites (ml) Nondetectable 4.571.2**
UO (ml/min) 9.870.7 11.171.0
PALAT (U/l) 38.771.8 64.174.6**
Pbilurubin (mmol/1) 1.870.1 104.975.2**
Pcr (mmol/1) 34.171.4 36.472.2
Ccr (ml/min) 1.5170.06 1.1170.12*
PNa (mEq/1) 138.670.5 139.670.7
PK (mEq/l) 5.570.1 4.670.2**
UNaUO (mmol) 1.2770.08 0.6370.11**
UKUO (mmol) 4.1970.10 3.3970.39
Sodium balance (mmol) 0.2670.07 0.5270.05*
FENa (%) 0.4270.02 0.2870.05*
FEK (%) 35.571.0 47.673.6**
Urine Na/K 0.3070.01 0.1970.03**
Paldosterone (pg/ml) 339753 357753
Uosm (mosm/kgH2O) 18267103 15287171
Posm (mosm/kgH2O) 29871 29871
U/Posm 6.170.4 5.170.6
Values are expressed as mean7s.e. These values are measured at the last day of
experiments (6 weeks). UO, urine output; Palat, plasma alanine aminotransferase;
Pbilurubin, plasma bilirubin; PNa, plasma sodium; PK, plasma potassium; Pcr, plasma
creatinine; Ccr, creatinine clearance; UNaUO, rate of urinary sodium excretion;
UKUO, rate of urinary potassium excretion; sodium balance, the difference
between dietary sodium intake and urinary sodium excretion in the 24 h; FENa,
fractional excretion of sodium in urine; FEK, fractional excretion of potassium in
urine; urine Na/K, urine sodium/potassium ratio; Paldosterone, plasma aldosterone;
Uosm, urine osmolality; Posm, plasma osmolality. *Po0.05, **Po0.01 compared with
control.
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(not shown) in kidneys from 6-week CBDL rats. Finally,
immunoperoxidase microscopy of sections from kidneys also
revealed increased apical immunolabeling of aENaC as well
in DCT2 (not shown), CNT (not shown), CCD (Figure 3a
and b) and OMCD (Figure 3c and d) in 6-week CBDL
rats.
Decreased protein expression of 11bHSD2 in rats with
6-week CBDL
The protein abundance of 11bHSD2 was significantly
decreased in the cortex/OSOM (40711 vs 100714%,
Po0.05, Figure 4a and b) and ISOM (71710 vs 10079%,
Po0.05). Immunoperoxidase microscopy also demonstrated
that the immunolabeling of 11bHSD2 was markedly
decreased in CNT (Figure 4c and d) and CCD (Figure 4e
and f).
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Figure 2 | Immunoperoxidase microscopy of bENaC and cENaC in the CNT and CCD. Immunoperoxidase labeling of bENaC is mainly
associated with the entire cytoplasm of principal cells of the CNT (a) and CCD (c) in control rats. In contrast, bENaC labeling was markedly
redistributed to the apical plasma membrane domains in CNT (b) and CCD (d) in 6-week CBDL rats. At 6 weeks, rats with CBDL showed
markedly increased apical labeling of gENaC in CNT (e, f) and CCD (g, h) compared with controls. Arrows indicate apical labeling. Original
magnification:  630.
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Figure 1 | Semiquantitative immunoblots of kidney protein
prepared from the cortex/OSOM and the ISOM from control and
6-week CBDL rats. The protein abundance of aENaC at 85 kDa band
was not changed in the cortex/OSOM, while it was increased in the
ISOM in rats with 6-week CBDL compared with controls. The
abundance of bENaC band at 85 kDa was not changed in the cortex/
OSOM and ISOM. The 85 kDa band abundance of gENaC was
decreased in the cortex/OSOM, but not in the ISOM. However, total
gENaC abundance and 70 kDa band expression were not changed in
the cortex/OSOM and ISOM. *Po0.05.
Table 2 | Densitometric analysis of ENaC expression in control
rats and rats with 6-week CBDL
Control Cirrhosis
(n=7) (%) (n=10) (%)
Cortex/OSOM
aENaC 100710 136729
bENaC 100717 93732
gENaC (total) 10076 82712
gENaC 85 kDa 10073 6577*
gENaC 70 kDa 100727 118740
ISOM
aENaC 100712 154710*
bENaC 100717 73737
gENaC (total) 10077 117713
gENaC 85 kDa 10075 8477
gENaC 70 kDa 100718 2477102
Values are expressed as mean7s.e. ENaC, epithelial sodium channel; OSOM, outer
stripe of outer medulla; ISOM, inner stripe of outer medulla. *Po0.05 compared with
control.
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Altered protein expression of the major renal sodium
transporters in rats with 6-week CBDL (Figure 5, Table 3)
The protein expression of a1-isoform of Na,K-ATPase was
decreased in the cortex/OSOM, but not in the ISOM.
Immunoblotting analysis revealed that type 3 Na/H exchan-
ger (NHE3) expression was decreased in the cortex/OSOM,
but not in the ISOM. Immunocytochemistry demonstrated
that the labeling of NHE3 in the proximal tubule in rats with
6-week CBDL was reduced, but maintained in the medullary
thick ascending limb (TAL) compared with control rats (not
shown). Immunoblotting analysis revealed a decreased
expression of Na–K-2Cl cotransporter (NKCC2) in the
cortex/OSOM in 6-week cirrhotic rats whereas it was not
altered in the ISOM. In contrast to the significant changes in
renal protein expressions of NHE3 and NKCC2 in rats with
6-week CBDL, immunoblotting analysis revealed unchanged
levels of Na–Cl cotransporter (NCC) in the cortex/OSOM.
Urinary sodium excretion and fractional excretion of sodium
were not changed in rats with 8-week CBDL (Table 4)
At 8 weeks, all CBDL rats developed significant ascites.
Plasma concentrations of ALAT and bilirubin were signifi-
cantly increased in rats with 8-week CBDL compared with
controls. Plasma creatinine levels were not changed, whereas
renal creatinine clearance was significantly decreased in rats
with liver cirrhosis. In contrast to reduced sodium excretion
in rats with 6-week CBDL, the 24-h urinary sodium excretion
and fractional excretion of sodium were not changed at 8-
week CBDL. Consequently, liver cirrhosis rats did not show
any changes in sodium balance, and the urinary Na/K ratio
and fractional excretion of potassium were also normal.
Interestingly, plasma aldosterone levels were significantly
decreased in 8-week CBDL.
The protein expression of ENaC subunits was decreased in
rats with 8-week CBDL
The protein abundance of all ENaC subunits was markedly
decreased in the cortex/OSOM in rats with 8-week CBDL
compared with controls (Figure 6). The abundance of bENaC
and gENaC was also decreased in the ISOM, while aENaC
expression was unchanged. The analyses of normalized band
densities are shown in Table 5. Thus, these changes may
promote sodium excretion in response to earlier sodium
retention.
The protein abundance of 11bHSD2 was decreased in the
cortex/OSOM and ISOM (Figure 6, Table 5).
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Figure 3 | Immunoperoxidase microscopy of aENaC in CCD and
OMCD. Immunoperoxidase labeling of aENaC is restricted to a
narrow zone in the apical part including the plasma membrane
domains of the principal cells of the CCD (a) and OMCD (c) in control
rats. In contrast, rats with 6-week CBDL revealed markedly increased
apical immunolabeling of aENaC in CCD (b) and OMCD (d). Arrows
indicate apical labeling. Original magnification:  630.
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Figure 4 | Semiquantitative immunoblotting and immunoperox-
idase microscopy of 11bHSD2 from control and 6-week CBDL
rats. (a) The immunoblot was reacted with anti-type 2 isoform of
11bHSD2 antibodies and revealed a single 44 kDa band. (b)
Densitometric analyses revealed that 11bHSD2 expression in the
cortex/OSOM was significantly reduced in rats with 6-week CBDL
compared with controls. Immunoperoxidase labeling of 11bHSD2 is
dispersed in the cytoplasm of principal cells of the connecting tubule
(CNT) (c) and cortical collecting duct CCD (e) in control rats. In rats
with 6-week CBDL, the immunolabeling intensity of 11bHSD2 was
markedly decreased in CNT (d) and CCD (f) compared with control
rats. *Po0.05.
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Decreased immunolabeling of ENaC subunits in rats with
8-week CBDL
bENaC labeling intensity was markedly decreased in the
principal cells of DCT2 (not shown), CNT (Figure 7a and b),
cortical (Figure 7c and d), and OMCD (not shown),
consistent with the immunoblotting analysis (Figure 6),
and the labeling was mainly cytoplasmic. The immunlabeling
intensity of gENaC was significantly decreased in DCT2 (not
shown), CNT (Figure 7e and f), cortical (Figure 7g and h)
and OMCD (not shown) in rats with 8-week cirrhosis
compared with controls, whereas the subcellular localization
did not change. The aENaC labeling was significantly
decreased in DCT2 (not shown), CNT (Figure 7i and j)
and the collecting duct (not shown) in rats with 8-week
cirrhosis compared with controls.
Altered protein expression of major renal sodium
transporters in rats with 8-week cirrhosis
The protein abundance of NHE3 was decreased in the cortex/
OSOM, while it was unchanged in the ISOM. In contrast, the
protein abundance of NCC, NKCC2 and a1 subunit of Na,
K-ATPase was not changed in the cortex/OSOM or ISOM in
rats with 8-week CBDL (Figure 8, Table 6). Immunocyto-
chemistry also revealed that the labeling of NHE3 in the
proximal tubule was reduced, but was unchanged in TAL in
rats with 8-week CBDL compared with control rats
(Figure 9). This is consistent with NHE3 protein abundance
in the cortex/OSOM, and unchanged NHE3 expression in the
ISOM as observed by immunoblotting.
DISCUSSION
Long-term bile duct ligation in rats is a well-known
experimental model of liver cirrhosis and portal hyperten-
sion, and has been widely used to study the renal mechanisms
of sodium retention.12 In the present study, CBDL rats
showed decreased fractional excretion of sodium and hence,
positive sodium balance in the sodium-retaining stage of liver
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Figure 5 | Semiquantitative immunoblotting of kidney protein
prepared from the OSOM and ISOM from control and 6-week
CBDL. In the cortex/OSOM, there was reduced abundance of Na,K-
ATPase a1 subunit, NHE3 and NKCC2, but unchanged abundance of
NCC in rats with 6-week CBDL. In contrast, in the ISOM, the protein
expression of Na,K-ATPase a1 subunit, NHE3 and NKCC2 was
unchanged in rats with 6-week CBDL when compared to controls.
*Po0.05.
Table 3 | Densitometric analysis of renal sodium transporter
expression in control rats and rats with 6-week CBDL
Control Cirrhosis
(n=7) (%) (n=10) (%)
Cortex/OSOM
Na,K-ATPase a1 100711 5676*
NHE3 100711 32713*
NKCC2 100712 6176*
NCC 10078 8375
ISOM
Na,K-ATPase a1 10079 10474
NHE3 100724 107716
NKCC2 100712 10576
Values are expressed as mean7s.e. NHE3, type 3 Na/H exchanger; NKCC2, Na-K-2Cl
cotransporter; NCC, Na–Cl cotransporter. *Po0.05 compared with control.
Table 4 | Changes in hepatic and renal function in control rats
and rats with 8-week CBDL
Control Cirrhosis
(n=7) (n=8)
Body weight (g) 30274 300715
Food intake (g) 19.070.2 17.871.4
Water intake (ml) 26.771.5 24.170.9
Ascites (ml) Nondetectable 8.572.0**
UO (ml/min) 13.371.4 11.571.0
Palat (U/l) 49.871.5 95.077.8**
Pbilurubin (mmol/1) 2.170.1 101.8711.5**
Pcr (mmol/l) 29.772.6 26.872.2
Ccr (ml/min) 1.5770.09 1.2670.08*
PNa (mEq/1) 138.370.4 139.370.6
PK (mEq/l) 4.9770.26 5.3670.17
UNaUO (mmol) 1.5770.07 1.1970.16
UKUO (mmol) 4.1670.14 3.4770.14**
Sodium balance, (mmol) 0.2370.07 0.3370.11
FENa (%) 0.5270.04 0.4770.06
FEK (%) 37.771.7 36.672.0
Urine Na/K 0.3870.01 0.3470.04
Paldosterone (pg/ml) 346758 18177*
Uosm (mosm/kgH2O) 16157176 17647194
Posm (mosm/kgH2O) 30071 30073
U/Posm 5.470.6 5.970.7
Values are expressed as mean7s.e. These values are measured on the last day of
experiments (8 weeks). UO, urine output; Palat, plasma alanine aminotransferase;
Pbilurubin, plasma bilirubin; PNa, plasma sodium; PK, plasma potassium; Pcr, plasma
creatinine; Ccr, creatinine clearance; UNaUO, rate of urinary sodium excretion;
UKUO, rate of urinary potassium excretion; sodium balance, the difference
between dietary sodium intake and urinary sodium excretion in the 24 h; FENa,
fractional excretion of sodium into urine; FEK, fractional excretion of potassium in
urine; urine Na/K, urine sodium/potassium ratio; Paldosterone, plasma aldosterone;
Uosm, urine osmolality; Posm, plasma osmolality. *Po0.05, **Po0.01 compared with
control.
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cirrhosis (at 6 weeks). It is suggested that increased renal
tubular absorption of sodium may account for the sodium
retention and pathogenesis of ascites formation. It is
noteworthy that at 8 weeks of CBDL, we did not see any
evidence of positive sodium balance even though all rats
showed marked ascites. These findings may suggest that there
are dynamic changes in sodium retention at different stages
(i.e., a sodium-retaining stage and a compensatory stage) of
liver cirrhosis. It should be emphasized that the two time
periods are two in a continuum of changes during the
development of sodium retention and the stages with partial
or full compensation.
In the present study, the most important finding is the
increased targeting of all ENaC subunits to the apical plasma
membrane domain in DCT2, CNT and collecting duct in the
sodium-retaining cirrhotic rats, but not in 8-week CBDL rats
Cortex/OSOM
Control
kDa
Control
(n=7)
ENaC∗
ENaC∗
ENaC∗
- 85
- 85
- 85
- 70
- 85
- 85
- 70
- 85
Cirrhosis
Inner stripe of outer medulla
Cirrhosis
(n=10)
11HDS2∗
ENaC
ENaC∗
ENaC∗
11HDS2∗
- 44
- 44
Figure 6 | Semiquantitative immunoblotting of kidney protein
prepared from the cortex/OSOM and ISOM from control and 8-
week CBDL rats. The protein abundance of all ENaC subunits
(aENaC, bENaC and gENaC) was markedly decreased in the cortex/
OSOM in rats with 8-week CBDL compared with controls. The
abundance of bENaC and gENaC was also decreased in the ISOM,
while aENaC expression was maintained. The protein expression of
11bHSD2 in the cortex/OSOM and ISOM was significantly reduced in
rats with 8-week CBDL compared with control rats. *Po0.05.
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Figure 7 | Immunoperoxidase microscopy of bENaC, cENaC and
aENaC in the CNT and CCD. In 8-week CBDL rats, immunoperox-
idase staining patterns for the ENaC subunits were similar in kidneys
from CBDL rats as compared to controls, with mainly cytoplasmic
labeling, indicating that the subcellular localization was not changed.
However, the immunolabeling intensity of ENaC subunits was
significantly decreased in CNT and CCD in CBDL (8 weeks)-induced
liver cirrhotic rats compared with controls. Original magnification:
 630.
Table 5 | Densitometric analysis of ENaC and 11bHSD2
expression in control rats and rats with 8-week CBDL
Control Cirrhosis
(n=7) (%) (n=8) (%)
Cortex/OSOM
aENaC 10078 5576*
bENaC 10076 3677*
gENaC (total) 100710 6379*
11bHSD2 10077 3774*
ISOM
aENaC 10077 83717
bENaC 100717 44711*
gENaC (total) 100716 5378*
11bHSD2 10074 7972*
Values are expressed as mean7s.e. ENaC, epithelial sodium channel; 11 bHSD2, type
2 isoform of 11b-hydroxysteroid dehydrogenase; OSOM, outer stripe of outer
medulla; ISOM, inner stripe of outer medulla. *Po0.05 compared with control.
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without positive sodium balance. Because increased ENaC
plasma membrane targeting is strongly associated with
increased sodium reabsorption, this finding very strongly
suggests that increased ENaC targeting contributes signifi-
cantly to the increased renal tubular sodium reabsorption.
Previous studies demonstrate that aldosterone causes a
dramatic redistribution of ENaC to the apical plasma
membrane.10,13 Thus, the increased apical targeting of ENaC
subunits in CBDL-induced liver cirrhosis may be caused by
increased aldosterone activity via stimulation of the MR in
the aldosterone responsive epithelium. As there was a
markedly enhanced apical plasma membrane expression of
all ENaC subunits at 6-week CBDL associated with main-
tained plasma aldosterone levels but not at 8-week CBDL
when aldosterone levels were markedly reduced, it is likely
that aldosterone plays an essential role. However, other
mechanisms may also contribute as discussed below.
In vitro studies have demonstrated that the MR has an
equal affinity for aldosterone and glucocorticoids,14 yet, in
vivo, it displays specificity for aldosterone in the face of much
higher circulating concentrations of glucocorticoids. This
specificity is conferred by 11bHSD2, an enzyme that converts
glucocorticoids to inactive 11-ketosteroid derivatives that
have weak or no affinity for the MR in mineralocorticoid-
sensitive tissues including the distal nephron.15 In the present
study, we demonstrate that there is a downregulation of
11bHSD2 abundance in the kidney in decompensated liver
cirrhotic rats. This finding is in line with recent studies in
compensated liver cirrhosis reported by Quattropani et al.16
and Escher et al.17 They demonstrated that 11bHSD2 activity
in the kidney was reduced in liver cirrhosis following bile
duct ligation.16,17 These findings together suggest that
reduced expression and activity provides a basis for access
of glucocorticoids to the MR, thereby promoting increased
collecting duct sodium reabsorption despite normal plasma
levels of aldosterone in rats with experimental liver cirrhosis.
Plasma aldosterone levels, at least in humans and rats
without liver cirrhosis, have been shown to be reduced in
conditions with low expression of 11bHSD2.18–20 It is
noteworthy that plasma aldosterone levels were not reduced
in rats with 6-week CBDL, despite the protein abundance of
11bHSD2 being significantly decreased. Thus, coordinated
activation of MR by both glucocorticoid as a consequence of
reduced activity of 11bHSD2 and by relatively high plasma
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Figure 8 | Semiquantitative immunoblotting of kidney protein
prepared from the cortex/OSOM and ISOM from control and
8-week CBDL rats. The protein abundance of NHE3 was decreased
in the cortex/OSOM, while it was unchanged in the ISOM. In contrast,
the protein abundance of NCC, NKCC2 and a1 subunit of Na,K-ATPase
was not changed in the cortex/OSOM or ISOM in rats with 8-week
CBDL. *Po0.05.
Control Cirrhosis
Co
rte
x
IS
O
M
a b
c d
PT
PT
PT
PT
PT
PT
PT
TAL TAL
TAL
TAL
G
G
Figure 9 | Immunoperoxidase microscopy of NHE3 in the prox-
imal tubule and thick ascending limb. In controls, NHE3 labeling
was seen in apical plasma membrane domains of proximal tubule
cells in the cortex (a) and TAL in the ISOM (c). In rats with 8-week
CBDL, the labeling of NHE-3 in the proximal tubule was reduced
(b) but not in TAL (d) compared with control rats. G, glomerulus; PT,
proximal tubule; TAL, thick ascending limb. Original magnification:
 250.
Table 6 | Densitometric analysis of renal sodium transporter
expression in control rats and rats with 8-week CBDL
Control Cirrhosis
(n=7%) (n=8%)
Cortex/OSOM
Na,K-ATPase a1 10078 8675
NHE3 10078 6978*
NKCC2 100718 11879
NCC 10078 110714
ISOM
Na,K-ATPase a1 10074 9677
NHE3 100717 104714
NKCC2 10079 92714
Values are expressed as mean7s.e. NHE3, type 3 Na/H exchanger; NKCC2, Na-K-2Cl
cotransporter; NCC, Na-Cl cotransporter. *Po0.05 compared with control.
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aldosterone may enhance distal renal tubular sodium
reabsorption and potassium loss, and hence play important
roles for the pathogenesis of sodium retention and possible
ascites formation in CBDL-induced liver cirrhosis. In
contrast, in response to CBDL for 8 weeks, ENaC abundance
was decreased and the reduction was associated with
decreased plasma aldosterone levels. In addition, the
increased apical targeting of ENaC subunits was retrieved
in spite of decreased abundance of 11bHSD2. It can be
speculated that 11bHSD2 is still functioning but not at
full power (thus aldosterone may play a major role), or it may
be speculated that differences in ENaC trafficking between
6 and 8 weeks are independent of aldosterone and/or
11bHSD2.
In normal rats, both the apical targeting and protein
abundance of aENaC are increased by high-dose aldosterone
treatment.10 However, in the present study, we did not
observe an increase in aENaC protein expression in the
cortex/OSOM in kidneys from rats with CBDL for 6 weeks,
although increased abundance of aENaC was seen in the
ISOM. It may be speculated that glucocorticoids may be
involved in this regulation, and if this is the case, the
observations suggest that regulation of aENaC abundance is
not as sensitive as the regulation of changes in the subcellular
localization of ENaC to MR activation by glucocorticoids.
Whether the differential regulation of ENaC subunit target-
ing and expression may be related to differences in
the kinetics of MR-ligand interaction remains unknown;
aldosterone dissociates more slowly from MR than cortisol
does, indicating that the stability of the aldosterone–MR
complex is higher than that of the cortisol–MR complex.21,22
In addition, the MR activity can be regulated by at the level of
transcription activation or repression by cell-specific
cofactors.23
It is also interesting to note that the rats with liver
cirrhosis apparently exhibited dynamic changes in sodium
retention and ENaC trafficking. After 6 weeks, CBDL animals
exhibited sodium retention, potassium loss and decreased
urine Na/K ratio, indicating increased aldosterone-like
activity. These findings can be explained in part by decreased
abundance of 11bHSD2, which permits the stimulation of
MR by glucocorticoid resulting in increased apical targeting
of ENaC subunits. On the other hand, at 8 weeks, the rats
with liver cirrhosis did not exhibit any changes in urinary
sodium and potassium excretion although they all had
marked ascites. The underlying mechanism for the time
course changes in circulating aldosterone levels and changes
in ENaC subunits trafficking remains undefined. However, it
can be speculated that at later stages of liver cirrhosis the rise
in extracellular fluid volume and enhanced secretion of atrial
natriuretic peptide contribute to the decrease in plasma
aldosterone levels and, hence, limit ENaC abundance/
trafficking as atrial natriuretic peptide has been known to
inhibit directly aldosterone secretion in the adrenal glands
through specific atrial natriuretic peptide receptors in the
zona glomerulosa.24
The abundance of Na,K-ATPase a1 subunit, NHE3 and
NKCC2 was either significantly decreased in the cortex/
OSOM or unchanged in the ISOM in the rats with 6-week
CBDL. These results are consistent with previous observa-
tions in 5-week CBDL-induced liver cirrhosis,25 which
indicate that tubular segments distal to the TAL are
responsible for the increased sodium reabsorption in
cirrhosis. The decreased abundance of NHE3, NKCC2 and
Na,K-ATPase in the cortex/OSOM may play a compensatory
role to promote sodium excretion in the sodium-retaining
stage. In addition, the decrease in NHE3 and NKCC2, as
observed in this study, may balance the decrease in
glomerular filtration rate, thus resulting in long-term
glomerulotubular balance.
Recently, it has been demonstrated that there is an increase
in NKCC2 expression in kidneys from rats with CCl4-induced
liver cirrhosis,26 while NKCC2 abundance was unchanged in
the ISOM or decreased in the cortex in CBDL rats, as
observed in this study. Consistent with this, CBDL-induced
liver cirrhosis in rats has previously been shown to be
associated with marked hypertrophy of the ISOM and with
either increased or maintained density of NKCC2 expression
per milligram total ISOM protein.27,28 Thus, total ISOM
expression is markedly increased in both settings. The data in
the present paper are fully consistent with this. In contrast to
the increased ENaC trafficking, the protein abundance of
NCC remained unchanged in the cortex in 6-week liver
cirrhosis. These findings may suggest that the regulation of
NCC protein abundance is not as sensitive as the regulation
of the subcellular localization of ENaC subunits to MR
activation by glucocorticoid in liver cirrhosis. It may also be
speculated that decreased glomerular filtration rate also plays
a role in the unchanged expression of NCC in spite of
increased MR activity.
CONCLUSIONS
The results strongly suggest that the marked increase in apical
ENaC subunit targeting combined with diminished abun-
dance of 11bHSD2 in the DCT2, CNT and collecting duct is
likely to play key roles for the sodium retention associated
with CBDL-induced liver cirrhosis in rats in the sodium-
retaining stage (i.e. in this model 6 weeks after CBDL). The
subsequent decrease in the expression of ENaC subunits and
the reduced targeting after 8 weeks of CBDL may contribute
to promoting sodium excretion at the later stages of liver
cirrhosis.
MATERIALS AND METHODS
Experimental protocols
Experiments were performed using male Munich–Wistar rats
(200–250 g, Møllegard Breeding Centre, Denmark), and all animal
procedures followed the guidelines for the care and handling of
laboratory animals established by the Danish government. Cirrhosis
was induced by CBDL as described by Kountouras et al.12 Control
rats were subjected to a sham operation where the bile duct was
isolated and manipulated but not ligated. Rats in two groups were
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pair fed. In the control group, rats were offered the amount of food
corresponding to the mean intake of food that the CBDL rats
consumed during the previous day.
During the last 3 days, the rats were maintained in metabolic
cages to allow urine collections. The rats were killed for
immunochemical and morphological studies at two different time
points (6 and 8 weeks after operation). Rats were anesthetized with
halothane (Halocarbon Laboratories, NJ). Blood was collected from
the inferior vena cava and analyzed for bilirubin, ALAT, Naþ , Kþ ,
creatinine, osmolality and plasma aldosterone concentration using
methods described previously.29
Semiquantitative immunoblotting
The dissected renal cortex/OSOM and ISOM were homogenized in
ice-cold isolation solution containing 0.3 M sucrose, 25 mM imida-
zole, 1 mM EDTA, 8.5 mM leupeptin, 1 mM phenylmethylsulfonyl
fluoride, with pH 7.2. The homogenates were centrifuged at 4000 g
for 15 min at 41C to remove whole cells, nuclei and mitochondria.
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis was
performed on 9 or 12% polyacrylamide gels. The proteins were
transferred by gel electrophoresis (BioRad Mini Protean II) onto
nitrocellulose membranes (Hybond ECL RPN3032D, Amersham
Pharmacia Biotech, Little Chalfont, UK). The blots were subse-
quently blocked with 5% milk in PBS-T (80 mM Na2HPO4, 20 mM
NaH2PO4, 100 mM NaCl, 0.1% Tween 20, pH 7.5) for 1 h and
incubated overnight at 41C with primary antibodies followed by
incubation with secondary anti-rabbit (P448, DAKO, Glostrup,
Denmark), anti-mouse (P447, DAKO) or anti-sheep (1713-035-147,
Jackson Laboratories) horseradish peroxidase-conjugated antibo-
dies. The labeling was visualized by an enhanced chemiluminescence
system (ECL or ECLþ plus).
Immunohistochemistry
A perfusion needle was inserted into the abdominal aorta and the
vena cava was cut to establish an outlet. Blood was flushed from the
kidneys with cold phosphate-buffered saline (pH 7.4) for 15 s before
switching to cold 3% paraformaldehyde in 0.1 M cacodylate buffer
(pH 7.4) for 3 min. The kidney was removed and sectioned into
2–3 mm transverse sections and immersion-fixed for an additional
1 h, followed by 3 10 min washes with 0.1 M cacodylate buffer of
pH 7.4. The tissue was dehydrated in graded ethanol and left
overnight in xylene. After embedding in paraffin, 2 mm sections of
the tissue were cut on a rotary microtome (Leica Microsystems A/S,
Herlev, Denmark). Immunoperoxidase labeling was performed as
previously described.29
Primary antibodies
We used previously characterized polyclonal antibodies. Affinity-
purified rabbit polyclonal antibodies were used against the renal
sodium transporters/channels (NHE3, NKCC2, NCC and the ENaC
subunits).29 A sheep polyclonal antibody to type 2 11bHSD2
(AB1296, Chemicon, Temecula, CA) was commercially obtained. A
mouse monoclonal antibody against the Na,K-ATPase a1-subunit
was kindly provided by Dr DM Fambrough, Johns Hopkins
University Medical School.
Statistical analyses
Values are presented as means7s.e. The statistical significance of
differences between the groups was determined using an unpaired
t-test.
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